Lung Cancer

CRANBURY, N.J.--( BUSINESS WIRE )--Physicians’ Education Resource ® (PER ® ), the leading resource for oncology and hematology continuing medical education, will present its 13 th Annual New York Lung Cancers Symposium® on Saturday, Nov. 10, at the New York Marriott Marquis. The program will be co-chaired by renowned oncologists, Mark G. Kris, M.D. , attending physician, thoracic oncology service, William and Joy Ruane Chair in Thoracic Oncology, Memorial Sloan Kettering Cancer Center, New York, and Roman Perez-Soler, M.D., chairman, department of oncology, Montefiore Medical Center, professor of medicine and molecular pharmacology, deputy cancer center director, Albert Einstein College of Medicine in New York. “We look forward to offering attendees an all new redesigned exciting meeting at this year’s 13th Annual New York Lung Cancer Symposium®,” said Phil Talamo, president of PER ® . “This year’s program will provide attendees with the chance to preview upcoming advances in loca

Conditions Andrea Barbalich Oct 30 Most people know to be suspicious of a stubborn cough—but that’s just one of the worrisome signs of lung cancer Detecting lung cancer create jobs 51/Shutterstock Each year, more than 234,000 people are diagnosed with lung cancer. It’s the leading cause of cancer death among both men and women, according to the American Cancer Society , with more people dying of lung cancer than colon, breast, and prostate cancers combined. Smokers are at greatest risk, but 10 to 15 percent of people with lung cancer have never smoked. In the earliest stages, there are no signs of  lung cancer, which is why screening is so important for people who are at higher risk: According to the U.S. Preventive Services Task Force (it reviews medical screenings), smokers—and former smokers—should get annual screenings between the ages of 55 and 80. However, as the cancer progresses, symptoms surface—some of which you might not expect. Learn the  11 facts doctors wish you k

DAVENPORT, Fla. —  To call the display in Christopher Bailey's front yard in Davenport a "pumpkin patch" would be a disservice. Bailey carves pumpkins year-round to display at Halloween Last year, Bailey's wife diagnosed with Stage 4 lung cancer GoFundMe page to benefit Moffitt Cancer Center "Three-hundred-sixteen of them, all different pumpkins, they're all unique," Bailey said. He's turned the orange orbs into "magical" works of art that delight children in his neighborhood. "I think that it's really amazing, and I just started coming to this neighborhood for Halloween last year, and this is just my favorite house," said Brianna Gill, 9. "I just get so into the Halloween spirit. I like all the pumpkins he sets up. I love what he's done this year with all the effects," said Payton James, 9. Inside the "Pumpkin House" in Davenport.  (Laurie Davison/Spectrum Bay News 9) Bailey carves out time

MANILA -- Lung cancer is treatable, and chemotherapy is not the only way to cure it, a health expert said Tuesday. “People can still be treated from lung cancer, but the treatment goals and management may depend on the stage, performance status, histology and molecular characteristic of the cancer. So those diagnosed with lung cancer should consult a medical oncologist to receive proper treatment,” Philippine Society of Medical Oncologists president Claire Soliman said during a roundtable discussion with the media in Mandaluyong City. Soliman said lung cancer treatment is made possible by a team of specialists – medical oncologists, surgical oncologists, radiation oncologists and pulmonologists. “Some patients would say: 'I have lung cancer ayoko na magpagamot dahil chemotherapy lang ang solusyon '. That’s not true because people with stage 4 lung cancer can also receive anti-cancer medications. We have new drugs called targeted therapy known as ‘magic pill’ in layman’s t

NEW YORK (GenomeWeb) – Taiwanese diagnostics firm PlexBio said today that it received CE marking for its IntelliPlex Lung Cancer Panel, an in vitro molecular diagnostic assay for the qualitative identification of 36 DNA mutations. The assay can identify mutations in the KRAS, NRAS, PIK3CA, BRAF, and EGFR genes, as well as 19 gene rearrangements of the ALK, ROS1, RET, NTRK1, and MET genes from formalin-fixed, paraffin-embedded tumor tissue from lung cancer patients, PlexBio said. It added that the assay leverages its SelectAmp and πCode technologies. The πCode technology is a circular disc that can generate more than 16,000 image patterns for multiplexing. According to the company's website, SelectAmp is a mutation-enriching PCR amplification method that increases mutation detection sensitivities. "We believe the benchmark established by our IntelliPlex Lung Cancer Panel with FFPE samples will provide the necessary foundation for the application to liquid biopsy as the nex

Please enable Javascript to watch this video CHICAGO, Illinois –  Lung cancer kills more Americans than breast, prostate and colon cancer combined . And like other forms of cancer, the earlier it's caught, the better chance patients have to survive. Now a new device is helping doctors diagnose lung cancer. 52-year old Ivy Elkins is a wife, mother of two teens and now an advocate for cancer research and treatment. Five years ago, Ivy's world turned upside down. "I was completely shocked when I found out I had lung cancer." Ivy was a non-smoker with no typical risk factors.   She went to the doctor with chronic pain in her elbow which turned out to be cancer that started in her lungs and spread to her bones and her brain. "I didn't know at that point what I know now," she remembered. "Anybody with lungs can get lung cancer." Ivy, like many patients, had no symptoms until after the cancer had spread. Dr. Kyle Hogarth worked clo

Another misconception about lung cancer is that there is not much hope once you are diagnosed. However, new research has provided amazing tools in the fight against lung cancer and is helping to change the outcomes, providing much needed hope for all diagnosed patients. In fact, there have been more advances made in the past two years than the past 10 years.   One advance from this type of pioneering research is the liquid biopsy. Physicians can now take a drop of blood, test or screen it, and see if your tumor ha s  a specific biomarker that may be treated with a targeted therapy. Researchers have learned that no two tumors are alike, similar to how each snowflake is unique. So, biomarker testing is used to identify the unique composition of each tumor and then targeted therapies are developed to attack tumors with specific biomarkers .   Even with these new precise treatments providing so much hope to lung cancer patients – there are still many unanswered questions and these tre

The US Food and Drug Administration (FDA) has approved Merck & Co’s Keytruda plus chemotherapy as a first-line treatment for non-small cell lung cancer (NSCLC). Following the results of a phase 3 trial, immunotherapy drug Keytruda (pembrolizumab) can be used in combination with carboplatin and either paclitaxel or nab-paclitaxel in patients with NSCLC. The combination was shown to be more effective than treating patients with chemotherapy alone. Keytruda is a type of programmed death-ligand 1 (PD-L1) inhibitor. Such drugs are immune checkpoint inhibitors that block PD-1 and PD-L1 proteins that stop the body’s immune system from attacking cancer cells. They essentially disrupt the cancer cells’ signals, exposing them to the body’s immune T-cells for attack. In the pivotal phase 3 trial of patients, regardless of tumour PD-L1 expression status, Keytruda plus chemotherapy (carboplatin and either paclitaxel or nab-paclitaxel) significantly improved overall survival (OS), reducing t

Christopher Bailey is helping his wife Adriana fight Stage 4 adenocarcinoma the best way he knows: with his love of Disney’s Haunted Mansion ride and all things Halloween. Bailey and Adriana both work at Disney World . In the front yard and garage of their Davenport home, Bailey created “Pumpkin House Fights Cancer.” The sprawling trick-or-treat paradise features a hi-tech homage to his favorite spooky ride and more than 300 pop-culture-referencing pumpkins he carved out of foam. Jack-O-Lantern halloween pumpkin with candles inside “I want this to be an experience that inspires people,” says Bailey, who works in Disney World’s entertainment division. “And an experience that helps people with cancer .” The haunt is free and an Instagrammer’s dream. Christopher is also hoping to raise awareness and donations for Tampa’s Moffitt Cancer Center through his playful, if incredibly detail-oriented creativity. Moffit is where Adriana is receiving treatment. The lung cancer she has is no

Conditions Andrea Barbalich Oct 30 Most people know to be suspicious of a stubborn cough—but that’s just one of the worrisome signs of lung cancer Detecting lung cancer create jobs 51/Shutterstock Each year, more than 234,000 people are diagnosed with lung cancer. It’s the leading cause of cancer death among both men and women, according to the American Cancer Society , with more people dying of lung cancer than colon, breast, and prostate cancers combined. Smokers are at greatest risk, but 10 to 15 percent of people with lung cancer have never smoked. In the earliest stages, there are no signs of  lung cancer, which is why screening is so important for people who are at higher risk: According to the U.S. Preventive Services Task Force (it reviews medical screenings), smokers—and former smokers—should get annual screenings between the ages of 55 and 80. However, as the cancer progresses, symptoms surface—some of which you might not expect. Learn the  11 facts doctors wish you k

Wellington-Dufferin-Guelph Public health is trying to get the word out on the dangers of radon gas in homes. Public Health is hosting a radon and lung cancer information session on Monday, Nov. 5 at Guelph’s West End Rec Centre. The free drop-in event runs from 5:00 p.m. to 7:30 p.m. READ MORE: What you should know about radon gas Story continues below Radon test kits will be available to purchase at the session for the discounted price of $35. During the month of November, discounted test kits can also be purchased online at  www.wdgpublichealth.ca/radon . The radioactive gas occurs naturally when the uranium in soil and rock breaks down. In enclosed spaces, radon — an invisible and odourless gas — can sometimes accumulate to high levels. According to Health Canada, long-term exposure to radon is linked to roughly 16 per cent of lung cancer deaths in Canada and is the second leading cause of lung cancer after smoking. A Health Canada survey found that about 18 per cent of homes tested

MEDIA CONTACT Available for logged-in reporters only Newswise — New Brunswick, N.J. – October 30, 2018 - November is Lung Cancer Awareness Month and in the United States, lung cancer remains the leading cause of cancer death among both men and women. The primary reason for high death rates for lung cancer is the fact that this disease is typically detected in very late stages, when treatment is often of little use. In 2011, the National Lung Cancer Screening Trial demonstrated that high-risk smokers who received a low-dose computed tomography scan for lung cancer screening had a 20 percent reduction in death from lung cancer and a seven percent reduction in all-cause death.  Patients from Rutgers Cancer Institute of New Jersey – one of 33 study sites – were included as part of the effort, which enrolled participants between 2002 and 2003. Although the scientific evidence is promising, lung cancer screening remains underutilized, with as few as four percent of eligible people

Li Hua Cui, 1 Hai Rong Xu, 2 Wu Yang, 1 Li Jiang Yu 1 1 Department of Oncology, People’s Hospital of Jingjiang, Jingjiang, China; 2 Department of Oncology, The Northern Jiangsu People’s Hospital, Yangzhou, China Background: Investigating the roles of lncRNA prostate cancer-associated transcript 6 (PCAT6) in modulating the growth and aggressiveness of non-small-cell lung carcinoma (NSCLC) cell. Method: The levels of PCAT6 in NSCLC tissues and cell lines were determined by quantitative real-time PCR assay. MTT as well as colony formation assays were applied to explore the effect of PCAT6 on the growth of NSCLC cell in vitro. Wound healing and Transwell assays were utilized to analyze the impact of PCAT6 on the migration and invasion of NSCLC cell. Bioinformatics analysis and luciferase reporter assay were used to prove that miR-330-5p was the target of PCAT6. Colony formation, wound healing, and Transwell invasion assays were applied to demonstrate that PCAT6 promoted NSCLC cell